VIPAR-C14ORF45 Fusion FISH Probe
The VIPAR-C14ORF45 Fusion FISH Probe is used to confirm a fusion of the VIPAR and C14ORF45 genes. The fusion of the VIPAR and C14ORF45 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| VIPAR-C14ORF45-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-RERE | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-REOR | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-REGO | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-REGR | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-OROR | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-GORE | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-GROR | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| VIPAR-C14ORF45-20-AQAQ | 20 (40 μL) | 200 μL |
|
Gene Diseases
The VIPAR C14ORF45 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|